Home / Stocks / RYTM

RYTM insider trading

RHYTHM PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-01Smith Hunter C
Chief Financial Officer
Sold62,774$105.46$6.6M
2026-08-14Mazabraud Yann
EVP, Head of International
Sold50,095$116.52$5.8M
2026-08-14Lee Jennifer Kayden
EVP, Head of North America
Sold75,834$117.38$8.9M
2026-06-24TETRAULT LYNN A.
Director
Sold37,000$100.32$3.7M
2025-11-12Cramer Pamela J.
Chief Human Resources Officer
Sold19,351$98.82$1.9M
2025-11-03Shulman Joseph
Chief Technical Officer
Sold9,748$115.24$1.1M
2025-09-04Shulman Joseph
Chief Technical Officer
Sold16,781$105.30$1.8M
2025-08-14Smith Hunter C
Chief Financial Officer
Sold24,611$96.33$2.4M
2025-07-11Smith Hunter C
Chief Financial Officer
Sold40,513$80.65$3.3M
2025-06-05MCGIRR DAVID W J
Director
Sold55,558$65.15$3.6M
2025-06-05Meeker David P
President and CEO
Sold43,346$65.04$2.8M
2025-06-03Smith Hunter C
Chief Financial Officer
Sold18,993$61.52$1.2M
2025-03-18Mazabraud Yann
EVP, Head of International
Sold55,803$51.72$2.9M
2024-11-13Lee Jennifer Kayden
EVP, Head of North America
Sold55,591$66.08$3.7M
2024-09-19GOOD JENNIFER L
Director
Sold31,751$52.40$1.7M
2024-09-11GOOD JENNIFER L
Director
Sold37,241$50.45$1.9M

See RYTM on the chart

Every insider buy and sell for RYTM plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.